⌘K

Login Start Free

Home/Filings/4/0001209191-21-071087

4//SEC Filing

Hoekman John 4

Accession 0001209191-21-071087

CIK 0001445499other

View on SEC.gov Company Profile

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 4:50 PM ET

Size

6.9 KB

Accession

0001209191-21-071087

Insider Transaction Report

Form 4

Period: 2021-12-22

IMPEL NEUROPHARMA INCIMPL

Chief Scientific Officer

Transactions

Exercise/Conversion
Stock Option (right to buy)
2021-12-22+20,000→ 0 total
Exercise: $1.64Exp: 2021-12-22→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock
2021-12-22$1.64/sh+20,000$32,800→ 128,221 total

Footnotes (1)

[F1]The option is 100% vested and exercisable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IMPEL NEUROPHARMA INC

CIK 0001445499

Entity typeother

Related Parties

1

filerCIK 0001855676

Filing Metadata

Form type: 4
Filed: Dec 22, 7:00 PM ET
Accepted: Dec 23, 4:50 PM ET
Size: 6.9 KB

View on SEC.gov